(Q42277253)
Statements
OBSERVE-5 interim analysis: an observational postmarketing safety registry of etanercept for the treatment of psoriasis (English)
David Pariser
Paul S Yamauchi
Alan Menter
Craig F Teller
Yifei Shi
Mellissa Yong
Kara Creamer
Michele Hooper
Girish Aras
Gregory Kricorian
26 January 2013